Indian companies continue to line up for initial public offerings (IPOs) despite the Covid-19 pandemic slowing down primary market activity from its first-quarter boom. Companies have filed draft red herring prospectuses (DRHPs) for nine IPOs that aim to raise almost Rs 19,660 crore (approximately $2.66 billion) since April 1, 2021, according to data from the primary market tracker Prime Database.

The primary market has hit the pause button. While 16 companies launched their IPOs in the first quarter of the calendar year, there was only one listing that of Macrotech Developers Ltd—in April.

According to bankers, companies that were working on their IPO plans have not held back and are continuing to file DRHPs so that they are ready when the second wave of the pandemic abates and markets are more conducive to IPOs.

• Ashoka Buildcon JV Bags Rs 1,041-Crore BMC Flyover Project; Shares End 2.30% Higher
• WPIL Shares End 7.75% Higher on Order Win
• Biocon Launches Diabetes, Obesity Drug-Device in Netherlands; Shares Trade Flat
• Bharat Electronics Shares Trade Higher on Rs 776 Crore Orders 
• Granules India Shares Slump Despite Securing EIR from USFDA 

“In the last three months a very strong IPO pipeline has built up. The filings that we saw in the last few weeks are all companies that have been working on their draft prospectuses for the last three-six months. While work on new deals has gone a little slow, companies that were in advanced stages are not looking to defer their IPO plans and continuing to file the prospectus,” said a Mumbai-based investment banker, who did not wish to be named.